According to public databases (TCGA), we inferred that high expression of either JMJD1B or JMJD1C indicates poor prognosis in ovarian cancer patients, corroborating their pro-tumorigenic function in ovarian cancer (Fig. 2C, D). This evidence concerns the gene KDM3B and ovarian cancer.